Timothy Sullivan

Insider Reports History

Location
Boston, MA
Signature
/s/ David Watson, attorney-in-fact for Timothy Sullivan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Timothy Sullivan:

Company Role Class Num Shares Value Price $ Report Date Ownership
Apellis Pharmaceuticals, Inc. Chief Financial Officer Common Stock 110,936 $3,109,536 $28.03 21 Oct 2025 Direct
Apellis Pharmaceuticals, Inc. Chief Financial Officer Stock Option (Right to Buy) 232,903 $1,599,675 $19.39 21 Oct 2025 Direct
Apellis Pharmaceuticals, Inc. Chief Financial Officer Common Stock 60,396 $1,366,761 $22.63 21 Oct 2025 The Timothy E Sullivan Irrevocable Trust of 2023

Insider Reports Filed by Timothy Sullivan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
APLS Apellis Pharmaceuticals, Inc. 21 Oct 2025 3 -$180,000 4 Chief Financial Officer 23 Oct 2025, 16:20
APLS Apellis Pharmaceuticals, Inc. 08 Sep 2025 4 -$1,039,679 4 Chief Financial Officer 10 Sep 2025, 16:02
APLS Apellis Pharmaceuticals, Inc. 09 Jun 2025 1 $1,599,675 4 Chief Financial Officer 11 Jun 2025, 16:20
APLS Apellis Pharmaceuticals, Inc. 29 Jan 2025 1 -$16,119 4 Chief Financial Officer 30 Jan 2025, 12:15
APLS Apellis Pharmaceuticals, Inc. 22 Jan 2025 1 -$93,953 4 Chief Financial Officer 23 Jan 2025, 15:37
APLS Apellis Pharmaceuticals, Inc. 17 Jan 2025 2 -$51,827 4 Chief Financial Officer 21 Jan 2025, 16:11
APLS Apellis Pharmaceuticals, Inc. 13 Jan 2025 1 -$62,283 4 Chief Financial Officer 14 Jan 2025, 16:25
APLS Apellis Pharmaceuticals, Inc. 31 Dec 2024 4 $154,825 4 Chief Financial Officer 03 Jan 2025, 16:09
APLS Apellis Pharmaceuticals, Inc. 18 Apr 2024 2 $0 4 Chief Financial Officer 19 Apr 2024, 19:27
APLS Apellis Pharmaceuticals, Inc. 01 Apr 2024 3 -$194,520 4 Chief Financial Officer 02 Apr 2024, 16:06
APLS Apellis Pharmaceuticals, Inc. 01 Mar 2024 4 -$319,160 4 Chief Financial Officer 05 Mar 2024, 16:04
APLS Apellis Pharmaceuticals, Inc. 12 Feb 2024 1 -$96,974 4 Chief Financial Officer 13 Feb 2024, 16:59
APLS Apellis Pharmaceuticals, Inc. 29 Jan 2024 1 -$58,109 4 Chief Financial Officer 31 Jan 2024, 16:34
APLS Apellis Pharmaceuticals, Inc. 22 Jan 2024 1 -$230,800 4 Chief Financial Officer 23 Jan 2024, 18:13
APLS Apellis Pharmaceuticals, Inc. 16 Jan 2024 3 $2,140,220 4 Chief Financial Officer 17 Jan 2024, 16:36
APLS Apellis Pharmaceuticals, Inc. 30 Nov 2023 4 -$632,879 4 Chief Financial Officer 01 Dec 2023, 16:11
APLS Apellis Pharmaceuticals, Inc. 03 Jul 2023 5 -$541,934 4 Chief Financial Officer 06 Jul 2023, 16:16
APLS Apellis Pharmaceuticals, Inc. 05 Jun 2023 6 -$5,496,643 4 Chief Financial Officer 06 Jun 2023, 16:59
APLS Apellis Pharmaceuticals, Inc. 03 May 2023 2 $0 4 Chief Financial Officer 03 May 2023, 16:22
APLS Apellis Pharmaceuticals, Inc. 19 Apr 2023 2 $0 4 Chief Financial Officer 20 Apr 2023, 16:15
APLS Apellis Pharmaceuticals, Inc. 21 Feb 2023 3 -$56,979 4 Chief Financial Officer 22 Feb 2023, 05:42
APLS Apellis Pharmaceuticals, Inc. 10 Feb 2023 1 -$49,929 4 Chief Financial Officer 14 Feb 2023, 15:59
APLS Apellis Pharmaceuticals, Inc. 27 Jan 2023 1 -$29,076 4 Chief Financial Officer 30 Jan 2023, 16:05
APLS Apellis Pharmaceuticals, Inc. 20 Jan 2023 1 -$123,826 4 Chief Financial Officer 24 Jan 2023, 16:23
APLS Apellis Pharmaceuticals, Inc. 25 Apr 2022 4 $2,274,016 4 Chief Financial Officer 17 Jan 2023, 19:00
APLS Apellis Pharmaceuticals, Inc. 10 Feb 2022 1 -$41,230 4 Chief Financial Officer 14 Feb 2022, 15:17
APLS Apellis Pharmaceuticals, Inc. 28 Jan 2022 1 -$25,083 4 Chief Financial Officer 01 Feb 2022, 17:05
APLS Apellis Pharmaceuticals, Inc. 21 Jan 2022 2 $0 4 Chief Financial Officer 25 Jan 2022, 15:57
APLS Apellis Pharmaceuticals, Inc. 08 Jun 2021 2 $399,996 4 Chief Financial Officer 09 Jun 2021, 16:06